Standard Deduction

Business

Apple Reportedly Shifts 2026 iPhone Strategy: Premium Models Take Priority, Standard Edition Faces Delay

Apple is reportedly planning to prioritize the launch of its three highest-tier iPhone models in 2026, while delaying the rollout of a new standard edition, according to a Nikkei Asia report citing sources familiar with the matter. The move signals a strategic pivot towards the premium segment amid ongoing supply chain considerations.

Jan 30, 2026

Business

Tax Season 2026: Sweeping Reforms Promise Fatter Refunds for Millions

As Americans begin filing their 2025 returns, a landmark tax overhaul passed by Congress is set to deliver significant savings for families, hourly workers, and homeowners through expanded deductions and new credits.

Jan 31, 2026

Business

Global Public Sector Gets Its Own Climate Disclosure Rulebook

IPSASB unveils the world's first dedicated climate reporting standard for governments and public bodies, mandating disclosures from 2028 to illuminate financial risks and opportunities.

Feb 2, 2026

Business

Wall Street Sounds Alarm on Private Credit Bubble, Putting High-Yield BDCs in the Spotlight

As warnings mount over loosening lending standards in the booming private credit market, investors are scrutinizing ultra-high-yield BDC stocks. While some show signs of stress, selective opportunities may still exist for those who look beyond the headline yield.

Feb 2, 2026

World

India Overhauls Tax Rules to Propel Homegrown Accounting Firms onto World Stage

In a bid to boost the global competitiveness of Indian accounting and advisory firms, the government has announced a dual-pronged reform: simplifying the 'accountant' definition under Safe Harbour Rules and merging tax computation standards with financial reporting norms.

Feb 2, 2026

Business

Prediction Markets Surge as Coinbase Expands Access and U.S. Regulators Signal Rule Overhaul

A pivotal week for prediction markets saw Coinbase partner with Kalshi to offer event contracts nationwide, while the CFTC moved to establish clearer regulatory standards. Meanwhile, traders sharply increased bets on a potential U.S. government shutdown.

Jan 30, 2026

Business

Bausch Health's Deep Discount: Market Overshoot or Justified Skepticism?

With shares languishing near $5.74, Bausch Health Companies (BHC) presents a stark valuation puzzle. While a standard DCF model suggests a staggering 91% undervaluation, the market's persistent sell-off reflects deep-seated concerns over the company's restructuring path and debt burden. We examine the numbers behind the divergence.

Feb 2, 2026

Business

Beyond the Roth Hype: Why Traditional Retirement Accounts May Be the Smarter Tax Move for Many

While Roth accounts dominate the retirement planning conversation, a closer look at current tax laws and long-term income strategies reveals a compelling case for prioritizing pre-tax contributions. We examine the data with an expert and explore what gold's historical returns tell us about diversification.

Jan 30, 2026

Business

Missouri Sports Betting Debut Sees Heavy Action But Ends in the Red

Missouri's inaugural month of legal sports betting attracted over $540 million in wagers, but aggressive promotions led to a net revenue loss for operators, even as the state collected millions in fees and taxes.

Jan 30, 2026

Business

AMD and GIGABYTE Forge Deeper Alliance, Bringing On-Device AI to Mainstream Gaming and Creator PCs

GIGABYTE is expanding its strategic partnership with AMD to launch a new generation of AI-enhanced gaming laptops, motherboards, and monitors. This collaboration integrates AMD's Ryzen AI and 3D V-Cache technologies directly into consumer hardware, aiming to deliver tangible benefits in gaming smoothness, system stability, and creative workflow acceleration.

Feb 2, 2026

Business

Navigating Economic Uncertainty: Nine Practical Strategies to Fortify Your Savings in 2026

Amid persistent inflation and shifting trade policies, building a robust financial safety net is more crucial than ever. Experts outline actionable steps to grow your savings, from debt management to smart account allocation.

Feb 2, 2026

FDA Rejects Aquestive's Oral Anaphylaxis Treatment, Leaving Patients Awaiting Epinephrine Alternative

The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.

Feb 2, 2026

Business

Eli Lilly Bets Nearly $2 Billion on Repertoire Immune Medicines to Pioneer Next-Generation Autoimmune Therapies

Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.

Feb 2, 2026

Business

Billion-Pound Ambition Meets Market Reality: Xeinadin Sale Shelved as Bidders Balk at Price

Private equity firm Exponent has halted the auction of UK accounting group Xeinadin after potential buyers refused to meet its £1bn valuation, signaling potential headwinds for deal-making in the professional services sector.

Feb 2, 2026

Business

Waymo Eyes $16 Billion Funding at Near $110 Billion Valuation, Fueling Autonomous Vehicle Race

Alphabet's self-driving unit Waymo is in advanced talks to secure a massive $16 billion funding round, potentially valuing the company at around $110 billion, as competition in the robotaxi market intensifies.

Feb 2, 2026

Business

Essar Commits $100 Million to Boost Gas Output from Key Indian CBM Field

Essar Oil and Gas Exploration & Production (EOGEPL) is injecting $100 million into its flagship Raniganj East CBM block in West Bengal, aiming to scale up domestic natural gas production and explore shale potential in a bid to reduce India's import reliance.

Feb 2, 2026

Business

Sonesta Unveils $400 Million Portfolio-Wide Revamp, Elevating Guest Experience Across Key Markets

Sonesta International Hotels concludes a sweeping multi-year renovation initiative, injecting modern amenities and design into properties from New York to Kaua'i, as the company sharpens its competitive edge in the hospitality sector.

Feb 2, 2026

Business

Analysts See Hidden Value in CuriosityStream: Stock Could Be Undervalued by Over 20%

A new financial analysis suggests shares of the documentary-focused streaming service CuriosityStream may be trading significantly below their estimated intrinsic value, presenting a potential opportunity for investors.

Feb 2, 2026

Business

NetEase Shares Dip: A Buying Opportunity or a Sign of Deeper Challenges?

Following a significant pullback, NetEase (SEHK: 9999) shares are trading at levels that some analysts deem undervalued. We examine the financial models, peer comparisons, and the broader sector headwinds facing the Chinese gaming giant to assess if the current price presents a strategic entry point for long-term investors.

Feb 2, 2026

Business

Cogent Biosciences Gains Key FDA Designations for Bezuclastinib, Spotlighting GIST Treatment Potential

Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.

Feb 2, 2026